Owner 3M Innovative Properties Company

Inventors Heppner, Philip D.; Merrill, Bryon A.; Rice, Michael J.; Haraldson, Chad A.; Johannessen, Sarah C.; Wurst, Joshua R.; Kshirsagar, Tushar A.; Niwas, Shri; Lindstrom, Kyle J.

Agent Phillips Ormonde Fitzpatrick

Pub. Number AU-B-2004278014

PCT Pub. Number WO2005/032484

Priority 60/508,634 03.10.03 US

Filing date 1 October 2004

Wipo publication date 14 April 2005

Acceptance publication date 28 April 2011

C07D 401/14 (2006.01) Heterocyclic compounds containing two or more hetero rings

A61K 31/4745 (2006.01)

A61K 31/496 (2006.01) - Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/5377 (2006.01)

A61K 31/541 (2006.01) - Non-condensed thiazines containing further heterocyclic rings

A61K 31/551 (2006.01) - having two nitrogens as ring hetero atoms, e.g. clozapine, dilazep

A61P 37/02 (2006.01) Drugs for immunological or allergic disorders

C07D 405/14 (2006.01) Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

C07D 471/04 (2006.01) Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups